Radiesse South Surrey

Radiesse is a calcium hydroxylapatite (CaHA) injectable biostimulator approved by Health Canada, designed to restore facial volume while supporting the skin's own collagen production.

Book an Appointment

Because every patient's facial structure, goals and medical history are different, Radiesse at our Dermapure South Surrey clinic always begins with a personalized consultation with a physician or healthcare professional. Together, you will discuss the areas you would like to treat, what a realistic treatment plan could look like and the possible side effects, which will be reviewed in detail during your consultation.

What to Expect During Your Session

Step 1

Personalized Assessment

During your consultation, a qualified provider will assess your facial structure, skin condition, and aesthetic goals. Based on this assessment, a personalized treatment approach will be discussed.

Step 2

Proceed with Treatment

Calcium hydroxylapatite (CaHA) injections are administered by a trained professional using an injection technique tailored to the treatment area. The procedure typically lasts 30–45 minutes. Patients may experience mild discomfort, and a numbing agent may be used to enhance comfort.

Step 3

Follow Up

A follow-up appointment may be recommended to assess the treatment area. As with any medical aesthetic procedure, individual experiences will vary, and further consultations may be scheduled based on personal needs and goals.

Follow-Up & Maintenance

Patients may choose to schedule follow-up treatments to maintain their desired appearance. The longevity of treatment effects depends on individual factors, and results may vary. A healthcare professional will guide you on an appropriate treatment schedule.

Contraindications

Calcium hydroxylapatite (CaHA) injections may not be suitable for individuals who are pregnant or breastfeeding; have a history of severe allergies or an allergic reaction to any of the product’s ingredients; have an active skin infection in the treatment area; or have a bleeding disorder or are taking blood thinners. A consultation with a qualified healthcare provider is required to determine whether this treatment is appropriate and to discuss potential risks and considerations.